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On a global scale, there has been a startling rise of diabetes in developing countries in recent years, especially type 2. One 
theory is that this may be linked to the 
switch to a diet more typical of developed 
countries – that is, one rich in high gly-
caemic index foods (World Health Organi-
zation, 2016; Carrera-Bastos et al, 2011).
It is the most common endocrine dis-
ease; since 1980, prevalence has risen from 
4.7% to 8.5% of the adult population 
(WHO, 2016).  
Figures for the UK show that there were 
around 3.2 million people with a diagnosis 
of diabetes in 2013. About 90% have the 
more common type 2 and 10% the rarer 
type 1 diabetes (National Institute for 
Health and Care Excellence, 2015). 
The disease was first recognised by the 
ancient Egyptians around 1500BC, and the 
term ‘diabetes mellitus’ coined by the 
Greek physician Aretaeus in the 1st cen-
tury AD. It literally means ‘running 
through of honey’, in reference to the 
finding of early physicians that patients 
Key points 
1 The defining feature of 
diabetes is increased 
blood glucose 
(hyperglycaemia)
2 Type 1 diabetes is characterised 
by a lack of insulin 
production, type 2 
by insulin resistance
3 Gestational diabetes 
increases the risk of 
higher birth weight 
in the child and 
subsequent type 2 
diabetes in the 
mother
4 Warning signs of diabetes include 
polyuria, glycosuria, 
polydipsia, 
polyphagia, 
ketoacidosis, weight 
loss, lethargy and 
visual disturbances
5 Diagnostic tests comprise the 
oral glucose 
tolerance test, 
measuring fasting or 
random blood 
glucose levels, and 
measuring glycated 
haemoglobin
produced increased amounts of urine with 
a distinctive sweet taste (Polonsky, 2012). 
Diabetes is a long-term metabolic dis-
order characterised by increased blood 
glucose (hyperglycaemia). If it is not effec-
tively controlled, it progressively dam-
ages many of the major organs and 
organ systems. 
Hormonal control of blood glucose
Glucose is the preferred energy source for 
human cells and it is transported around 
the body by the blood. The concentration 
of glucose in the blood is regulated by sev-
eral hormones, most of which increase the 
level of circulating glucose. Ideally, levels 
are maintained at 4-6mmol/L (Marieb and 
Hoehn, 2015; VanPutte et al, 2013).
The following hormones increase blood 
glucose:
l	 	Somatotropin (growth hormone): 
produced by the anterior pituitary 
gland; it increases blood glucose to 
provide energy for growth and repair;
l	 	Adrenaline (epinephrine): produced by 
the adrenal gland (medulla); it increases 
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Abstract Insulin is the only major hormone that reduces blood glucose levels, so 
people with insulin resistance or impaired insulin production display hyperglycaemia, 
which is the defining feature of diabetes. The two most common forms are type 1 
diabetes (an autoimmune disease where the immune system destroys the insulin-
producing cells of the pancreas) and type 2 (characterised by gradual resistance to 
the effects of insulin). This article, the first of a three-part series on diabetes 
management, gives an overview of the different types of diabetes (including rarer 
forms), causes and triggers, symptoms and warning signs, and diagnostic tests.
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In this article...
l   Features and warning signs of the common and rarer forms of diabetes
l   Established causes of, and suspected triggers for, diabetes
l   Diagnostic tests used to confirm diabetes
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Unlike type 2 diabetes, the onset of 
type 1 is usually rapid and the disease can 
be treated only with insulin, usually via 
regular injection, to normalise the blood 
glucose concentration. Without insulin 
therapy, patients would not survive. Before 
insulin became available, people with dia-
betes would rapidly enter states of keto-
acidosis and/or hyperglycaemic coma, or 
gradually become emaciated, before 
starving to death (Rajashree et al, 2012). 
Technological advances – particularly 
the introduction of continuous blood glu-
cose monitoring and automated insulin 
pumps – are revolutionising treatment of 
type 1 diabetes (Tumminia et al, 2015). Cur-
rent stem-cell research is examining the 
feasibility of pancreatic beta cell trans-
plants to restore insulin production, 
thereby potentially curing the disease 
(Kim et al, 2016).
Type 2 diabetes 
Type 2 diabetes (Table 1) is characterised by 
insulin resistance: affected individuals 
gradually become less responsive to the 
hormone. It is recognised as a separate 
condition to type 1, as most people retain a 
population of insulin-producing beta cells.
Until recently, the disease was com-
monly referred to as maturity-onset dia-
betes, since it usually occurred in over-
weight people of middle age; this term is 
no longer used, as type 2 also occurs in 
younger age groups. It is more frequent in 
people of African, South Asian and Afro-
Caribbean descent, but it can affect people 
from all ethnic backgrounds (NICE, 2015). 
Despite decades of intensive research, 
the exact cause of type 2 diabetes is still to 
over 40 million people worldwide (WHO, 
2016). It usually occurs in childhood: it is 
most frequently diagnosed between the 
ages of four and five years or in adoles-
cence; diagnoses then become progres-
sively rarer with age (Ozougwu et al, 2013). 
A classic autoimmune disease, type 1 
diabetes is characterised by the progres-
sive destruction of insulin-producing beta 
cells of the pancreas. Genetics influences 
individual susceptibility to type 1 diabetes, 
and around 10% of people with type 1 dia-
betes have a parent, sibling or child with 
the condition (Ferrannini et al, 2010). 
A variety of genes that predispose individ-
uals to autoimmune disease have been 
associated with type 1 diabetes (Pociot and 
Lernmark, 2016). 
It has been speculated that type 1 dia-
betes may also be triggered by a viral infec-
tion in early childhood, and many viruses 
have been suggested as potential triggers, 
including  rubella, mumps, cytomegalo-
virus and a variety of enteroviruses 
including poliovirus (Filippi and Von Her-
rath, 2008). Certain foods such as root veg-
etables, eggs and cow’s milk have also 
recently been proposed as triggers, par-
ticularly when eaten in infancy (Rewers 
and Ludvigsson, 2016).
Due to the destruction of the insulin-
producing beta cells, people with type 1 
diabetes either no longer produce any 
insulin, or produce it in such small 
amounts that it cannot have any useful 
physiological effect. Without insulin to 
bind to receptors on the surface of the 
cells, Gluts remain in the cells and glucose 
cannot move from the blood into the cells, 
resulting in hyperglycaemia. 
blood glucose to supply extra energy to 
the muscles when the body prepares for 
immediate action;
l	 	Cortisol: produced by the adrenal gland 
(cortex); released following prolonged 
stress or starvation. It increases the 
conversion of fat and protein into 
glucose and ketones such as acetone, 
which can be used in metabolism;
l	 	Glucagon: produced by the alpha cells 
of the pancreas when blood glucose 
levels drop; it increases and maintains 
blood glucose between major meals and 
during sleep.
The insulin response
While several hormones increase blood 
glucose, only one major hormone has the 
opposite effect, that of reducing the 
amount of glucose in the blood: insulin. 
This is a small polypeptide hormone that is 
released directly into the blood and rapidly 
circulated to all areas of the body (Van-
Putte et al, 2013). The insulin response 
(Fig 1) works as follows: after a meal rich in 
carbohydrates:
l	 	Blood glucose levels rise quickly;
l	 	Insulin-producing beta cells in the 
pancreas respond rapidly by releasing  
insulin;
l	 	Insulin is released into the blood and 
circulated to all areas of the body;
l	 	Insulin binds to receptors present on 
the surface of all human cells;
l	 	Small-channel proteins called glucose 
transporters (Gluts) move onto the cell 
membrane, allowing glucose to move 
rapidly from the blood into the cells, 
where it can be used for energy; 
l	 	Most of the glucose enters the liver and 
muscle cells, where it can be stored in 
the form of starch (glycogen) for later 
use (Marieb and Hoehn, 2015). 
Role of insulin in fat deposition
If excess carbohydrate is consumed, 
insulin promotes the uptake of glucose 
into the adipocytes – which form adipose 
tissues under the skin and around many of 
the internal organs, where it is rapidly con-
verted into fat and stored (Guyton and 
Hall, 2015). Insulin is the key hormone in 
fat deposition, and low-carbohydrate diets 
are effective because they result in 
decreased insulin production and there-
fore reduced fat deposition.
Types of diabetes
Type 1
The rare form of diabetes is type 1 (Table 1); 
it has a prevalence of about 10% in those 
diagnosed with the condition, equating to 
Fig 1. The insulin response
Insulin 
receptor
In the presence of insulin, Glut4 
vesicles fuse with the plasma 
membrane
Glut = glucose transporter.
Glut4 allows glucose to  
enter the cell
Insulin Glucose
Plasma 
membrane
Vesicle
Glut4
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improved or even reversed by exercise and 
diet (Hordern et al, 2012).
Rare forms of diabetes
There are rarer forms of diabetes, which 
account for 2% or less of the total number 
of cases. 
Maturity-onset diabetes of the young
Maturity-onset diabetes of the young is a 
dominant genetic disorder with signs and 
symptoms similar to type 2 diabetes but 
with a much earlier onset, usually in child-
hood. Since it is caused by a single gene 
mutation, it is a mononuclear genetic dis-
order and can usually be traced through a 
family’s generations in a predictable 
manner (Diabetes UK, 2017a).
Secondary diabetes
Secondary diabetes, as its name implies, 
arises as an effect of either another disease 
or a medication. Pancreatitis, pancreatic 
cancer and cystic fibrosis often cause 
extensive damage to the pancreas. If 
enough insulin-producing beta cells are 
destroyed in the process, patients with 
these conditions will develop a poor 
response to insulin, which in turn will pro-
duce the signs and symptoms of diabetes. 
Many steroidal drugs, particularly those 
given at high doses to treat long-term 
inflammatory conditions, can lead to ele-
vated blood glucose levels. Steroid-induced 
diabetes is not a ‘true’ form of diabetes, 
because it may subside when steroids are 
discontinued. As a result, it is often 
l	 	Raised cholesterol levels;
l	 	Increased risk of blood vessel damage 
and thrombosis (clot formation).
Gestational diabetes
Gestational diabetes is a temporary form of 
the disease seen in about one in nine preg-
nant women. It results in more sugar 
crossing the placenta, which often 
increases fat deposition in the foetus and 
makes it grow larger. These macrosomic 
(large-bodied) babies typically have a much 
higher birth weight than average (com-
monly over 4.5kg), which means that an 
assisted delivery is often needed. 
In most affected women, blood sugar 
levels return to normal after delivery; how-
ever, research indicates that they are at 
increased risk of developing type 2 dia-
betes later in life (Baz et al, 2016).
Impaired glucose tolerance
In impaired glucose tolerance (IGT), blood 
glucose levels are above normal but below 
those seen in diabetes, so IGT is often 
referred to as ‘pre-diabetes’. It is most 
easily diagnosed with a standard oral glu-
cose tolerance test (OGTT) where the 
results fall between the normal and dia-
betes curves. Individuals with IGT are 
regarded as pre-diabetic and at great risk 
of developing type 2 diabetes unless they 
make significant lifestyle changes. 
Having IGT also appears to increase the 
risk of coronary artery disease and myo-
cardial infarction (George et al, 2015; Xu et 
al, 2015). Research indicates that IGT can be 
be established. Various hypotheses for the 
causes of insulin resistance have been pro-
posed, including:
l	 	Interference with the ability of insulin 
to bind to its receptors; something – 
antibodies, viruses and proteins have 
all been suggested – acts to block the 
insulin receptor, preventing insulin 
from binding to it; 
l	 	Gene mutations that change the shape 
of the insulin receptor, making it more 
difficult for insulin to bind to it;
l	 	A variety of other factors commonly 
seen in type 2 diabetes, such as 
increased central body fat, increased 
secretion of steroid hormones such as 
cortisol, and increased fatty deposition 
in the liver (Ozougwu et al, 2013).
Without an adequate insulin response, 
glucose cannot pass into the cells of the 
body and remains in the blood, leading 
to hyperglycaemia.
Once diagnosed, patients with type 2 
diabetes are normally treated via a com-
bination of diet, exercise and oral antidia-
betic drugs such as metformin. Although 
type 2 diabetes is often referred to as non-
insulin-dependent, people may also inject 
insulin as part of their treatment regimen 
(Ahmann, 2015).
Type 2 diabetes is also frequently 
accompanied by some or all of the features 
of the so-called metabolic syndrome 
(NICE, 2015), which include:
l	 	A body mass index in the ‘overweight’, 
‘obese’ or ‘morbidly obese’ categories;
l	 	Hypertension (high blood pressure);
Nursing Practice
Review
Table 1. Features of type 1 and type 2 diabetes
Type 1 diabetes Type 2 diabetes
Nature of the 
disease
Autoimmune disease in which insulin-
producing beta cells in the pancreas are 
depleted
Insulin resistance; the exact cause has yet to be established, but it is 
thought to involve problems in insulin’s interactions with its receptors
Onset Typically rapid Generally slow and often insidious
Age of onset Usually early childhood, but can be any age Used to be middle age, but now also increasingly younger age
Prevalence Around 10% Around 90%
Risk factors l Genetic predisposition 
l Environmental factors, particularly certain 
viral infections 
l Possibly foods such as certain root 
vegetables, eggs and cow’s milk, particularly 
when eaten in infancy
l High body mass index (particularly obese and morbidly obese 
categories) 
l A large waist (>80cm/31.5in in women and >94cm/37in in men) 
l Genetic predisposition 
l African-Caribbean, black African, South Asian and Chinese descent 
l Pre-existing cardiovascular disease 
l Mental health problems or learning difficulties (NICE, 2012)
Warning 
signs
Increased thirst and urination, glycosuria, 
tiredness, weight loss (often rapid), blurred 
vision, constant hunger
Feeling ‘washed out’, frequent urination that can disturb sleep, thirst 
that is difficult to quench, blurred vision, frequent infections 
(particularly fungal and bacterial), poor/delayed wound healing
Treatment Insulin Diet, exercise, weight loss, oral hypoglycaemics (e.g. metformin); 
insulin often used as well
43Nursing Times April 2017 / Vol 113 Issue 4 www.nursingtimes.net
Fasting and random blood glucose levels
Other methods used to diagnose diabetes 
have gradually become accepted (WHO, 
2006); their advantage is that they can be 
readily carried out by a health professional 
in a GP surgery or even in the 
patient’s home:
l	 	A fasting blood glucose level >7mmol/L 
(NICE, 2016), ideally recorded on two 
separate occasions (fasting means 
having no calorific intake from food or 
beverages for at least eight hours);
l	 	A random blood glucose level 
>11mmol/L in a patient with classic 
symptoms of hyperglycaemia (Diabetes 
UK, 2017b); this reading can be taken at 
any time of day or night. Results should 
be treated with caution and it is a good 
idea to ask about the patient’s food 
l	 	Insulin will promote the rapid uptake 
of glucose into cells and the gradual 
reduction of glucose in the blood;
l	 	At the end of the two-hour period, 
glucose concentrations will be close to, 
or just above, the fasting reading. 
In a patient with diabetes, the test 
results will show:
l	 	Fasting blood glucose concentration 
will be higher than normal (>7mmol/L);
l	 	After the glucose solution has been 
drunk, blood glucose levels can rise as 
high as 11mmol/L or beyond;
l	 	Due to the lack of an insulin response, 
blood glucose levels will remain high 
for the remainder of the two-hour test.
Fig 2 shows the changes in blood glu-
cose levels typically seen in an OGTT in a 
healthy subject and in one with diabetes. 
referred to as pseudo diabetes; however, it 
often produces many of the classic signs 
and symptoms of diabetes. 
When investigating patients with sus-
pected diabetes, it is important to consider 
the possibility of secondary diabetes, as 
many people have been wrongly diagnosed 
with type 2 diabetes when they actually 
had pancreatic disease or adverse drug 
reactions (Diabetes UK, 2015; Chun, 2015).
Clinical features 
The defining feature of diabetes is hyper-
glycaemia. In a type 1 diabetes patient, it 
can occur rapidly with pronounced symp-
toms, as pancreatic insulin-producing 
beta cells are rapidly destroyed. In a patient 
with type 2 diabetes, hyperglycaemia usu-
ally develops gradually over a longer 
period of time, leading to less pronounced 
symptoms that many learn to live with. 
Some people with type 2 diabetes may 
be asymptomatic at the time of diagnosis. 
As a result, in type 2 diabetes, diagnosis is 
often delayed, sometimes by many years, 
and when the disease is finally confirmed, 
irreversible damage to many organs and 
tissues may have already occurred. 
The gradual and often insidious onset of 
type 2 diabetes also helps explain why there 
are an estimated 1.1 million undiagnosed 
people in the UK today (Diabetes UK, 2016). 
Box 1 lists the key symptoms that should 
raise suspicion of diabetes in undiagnosed 
patients. Patients describing any or a com-
bination of the symptoms listed in Box 1 
should ideally be tested to establish 
whether or not they have diabetes, as well 
as to rule out other medical conditions.
Diagnostic tests 
Oral glucose tolerance test
The OGTT is the gold standard for diag-
nosing diabetes (Sacks, 2011); it is the only 
test that gives a ‘real-time’ assessment of 
the insulin response. It requires:
l	 	Overnight fasting of at least eight hours; 
l	 	Admission to a clinic and having a 
fasting blood glucose measurement;
l	 	Consumption  of an oral solution 
containing a fixed amount of glucose 
(normally 75g);
l	 	Blood glucose levels being measured 
every 30 minutes thereafter during a 
two-hour period,
In a healthy patient the test will show: 
l	 	Fasting blood glucose level to be 
normal (3.9-5.5mmol/L);
l	 	After the glucose solution has been 
drunk, blood sugar levels will rise 
rapidly, triggering the release of 
insulin;
Box 1. Warning signs of diabetes
l Polyuria (increased urine production)
Increased glucose from the blood accumulates in the kidney tubules, attracting large 
amounts of water by osmosis. Urine output increases from around 1.8L seen in 
healthy people to typically over 3L, in those with diabetes. Polyuria is a common 
reason undiagnosed patients visit their GP, as it often disrupts sleep
l Glycosuria (sugar in the urine)
Patients produce urine containing large amounts of glucose. Normally, glucose is 
reabsorbed from the kidney tubules back into the blood; in diabetes, the amount 
overwhelms reabsorption mechanisms. The presence of glucose in urine can be 
checked with urinalysis strips
l Polydipsia (increased thirst)
Producing large amounts of urine rapidly leads to dehydration, triggering thirst that is 
difficult to satisfy. This is another common reason why people visit their GP
l Polyphagia (increased hunger)
Although there may be large amounts of sugar in the blood, it does not reach the 
cells to be used as an energy source. Effectively, patients are in a state of starvation, 
which triggers the release of hunger hormones such as cortisol and ghrelin. Patient’s 
will experience an increase in their appetite, but many will crave and eat sugary and 
starchy foods, exacerbating their condition
l Ketoacidosis
With no sugar to fuel metabolism, the body uses other molecules such as proteins 
and fats. Breaking down fat (lipolysis) leads to the generation of ketones such as 
acetone, which can be used in metabolism. Ketones are mildly acidic, but reduce 
blood pH if they accumulate in large amounts, resulting in ketoacidosis. Unless 
treated quickly, this medical emergency can lead to coma and death; it can present as 
increased breathing rate (Kussmaul breathing) and a fruity smell on the breath, and in 
the sweat and urine. It may also manifest as general abdominal pain, decreased 
appetite and nausea and vomiting 
l Weight loss
The metabolism of fat and protein in diabetes can lead to significant and 
unintentional weight loss, particularly in type 1 diabetes
l Lethargy
Glucose is the primary energy source for muscles; the lack of glucose uptake leads to 
fatigue, which is often compounded by the sleep interruptions
l Visual disturbances
Blurred vision and ‘black spots’ in the field of view may indicate damage to the lens 
and retina
Sources: Diabetes UK (2017c), Guyton and Hall (2015), Marieb and Hoehn (2015), McCance and 
Huether (2015)
For more articles  
on diabetes, go to  
nursingtimes.net/diabetesnursing
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Glycated haemoglobin
Erythrocytes (red blood cells) are unusual 
in that they have permanent Gluts in their 
cell membranes. Glucose is therefore con-
tinually entering erythrocytes, where it 
binds to red-pigment haemoglobin, 
resulting in glycated (or glycosylated) hae-
moglobin (HbA1c). The more glucose in 
the blood, the greater the amount of HbA1c 
in the erythrocytes. Unlike white blood 
cells (leukocytes), erythrocytes have a long 
lifespan, typically circulating for over 100 
days (Guyton and Hall, 2015). Assessing 
HbA1c therefore gives GPs and diabetes 
clinics a good overall picture of patients’ 
blood glucose control over the past two to 
three months. 
HbA1c testing is traditionally used as a 
method of assessing a patient’s adherence 
to their prescribed treatment. However, in 
2011, the WHO recognised it as an addi-
tional method of diagnosis. In health, 
normal values are <5%; values consistently 
>6.5% are taken to be strongly indicative of 
diabetes (NICE, 2016; WHO, 2011). 
There are limitations to the use of 
HbA1c as a diagnostic tool for diabetes. It 
is of most value in diagnosing classic 
type 2 diabetes and is not appropriate for 
the following patient groups (Diabetes UK, 
2017b):
l	 	Children and young people;
l	 	Those of any age suspected of having 
type 1 diabetes;
l	 	Patients who have had symptoms of 
diabetes for less than two months;
l	 	Patients at high risk of diabetes who are 
acutely ill (for example, those who 
require hospital admission);
l	 	Patients taking medication that may 
cause rapid blood glucose levels rise, 
for example, steroids or antipsychotics;
l	 	Patients with acute pancreatic damage, 
including those who have undergone 
pancreatic surgery;
l	 	Pregnant women;
l	 	Patients who have genetic, 
haematological and illness-related 
factors that may infl uence HbA1c and 
its measurement. NT
l This three-part series discusses current 
knowledge about diabetes, its eff ects on 
the human body and the implications for 
patients and health professionals. The 
second article (page 45) explores 
associated pathologies and examines the 
cumulative eff ects of poorly controlled 
blood glucose on the body; the third, to be 
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l		Reversing type 2 diabetes with 
lifestyle change
 Bit.ly/NTReversingDiabetes
Fig 2. Changes in blood glucose levels measured by the OGTT 
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